Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Oct;11(10):589-98.
doi: 10.1038/nrneph.2015.128. Epub 2015 Aug 11.

Vascular complications in autosomal dominant polycystic kidney disease

Ronald D Perrone  1 , Adel M Malek  2 , Terry Watnick  3
Affiliations
Review

Vascular complications in autosomal dominant polycystic kidney disease

Ronald D Perrone et al. Nat Rev Nephrol. 2015 Oct.

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease. Relentless cyst growth substantially enlarges both kidneys and culminates in renal failure. Patients with ADPKD also have vascular abnormalities; intracranial aneurysms (IAs) are found in ∼10% of asymptomatic patients during screening and in up to 25% of those with a family history of IA or subarachnoid haemorrhage. As the genes responsible for ADPKD—PKD1 and PKD2—have complex integrative roles in mechanotransduction and intracellular calcium signalling, the molecular basis of IA formation might involve focal haemodynamic conditions exacerbated by hypertension and altered flow sensing. IA rupture results in substantial mortality, morbidity and poor long-term outcomes. In this Review, we focus mainly on strategies for screening, diagnosis and treatment of IAs in patients with ADPKD. Other vascular aneurysms and anomalies—including aneurysms of the aorta and coronary arteries, cervicocephalic and thoracic aortic dissections, aortic root dilatation and cerebral dolichoectasia—are less common in this population, and the available data are insufficient to recommend screening strategies. Treatment decisions should be made with expert consultation and be based on a risk-benefit analysis that takes into account aneurysm location and morphology as well as patient age and comorbidities.

PubMed Disclaimer

Conflict of interest statement

Competing interests

The other authors declare no competing interests.

Figures

Figure 1
Figure 1
An aortic aneurysm in a 19-year-old patient with ADPKD. 3D magnetic resonance angiogram showing the ascending aortic aneurysm (arrow). Abbreviation: ADPKD, autosomal dominant polycystic kidney disease. Permission obtained from the American Society of Nephrology © Liu, D. et al. J. Am. Soc. Nephrol. 25, 81–91 (2014).
Figure 2
Figure 2
Right vertebral artery dissection in a 47-year-old patient with ADPKD. a | Angiogram b | 3D rotational angiogram and c | 3T magnetic resonance angiogram showing a spontaneous asymptomatic nontraumatic right vertebral artery dissection (dual arrows) and associated pseudoaneurysm (single arrow) with non-haemodynamically significant stenosis. The patient also had an unruptured intracranial aneurysm (shown in Figure 3). Abbreviation: ADPKD, autosomal dominant polycystic kidney disease.
Figure 3
Figure 3
An unruptured intracranial aneurysm in a 47-year-old patient with ADPKD and distant smoking history. The patient underwent screening for assessment of suitability for transplant. a | 3T magnetic resonance angiograms showing an unruptured 5 mm aneurysm in the anterior communicating artery. b–c | 3D rotational angiograms confirming the presence of the aneurysm. d | 3D rotational angiogram showing the aneurysm after treatment using endovascular coiling. e | Magnetic resonance angiogram showing the stable aneurysm at 3-year follow up. Arrows indicate the position of the aneurysm. Abbreviation: ADPKD, autosomal dominant polycystic kidney disease.
Figure 4
Figure 4
Pkd1 deletion in VSMCs results in abnormal proximal ascending aortic architecture. Ascending aortic sections from 6-month-old mice with (Pkd1VSMC−) and without (Pkd1VSMC+) selective deletion of Pkd1 in VSMCs were stained with Verhoeff–Van Gieson. a | Intact elastic fibre architecture in the aorta of a Pkd1VSMC+ mouse. b–d | Aortic sections from Pkd1VSMC− mice demonstrate diffuse fragmentation of elastic fibres and increased extracellular matrix deposition. e | Blinded quantitative histologic evaluation of aorta architecture scored by three observers (n = 8). *P = 0.001. Abbreviation: VSMC, vascular smooth muscle cell. Permission obtained from the American Society of Nephrology © Liu, D. et al. J. Am. Soc. Nephrol. 25, 81–91 (2014).
Figure 5
Figure 5
A ruptured intracranial aneurysm in a 46-year-old patient with ADPKD. a | CT scan showing diffuse subarachnoid haemorrhage and hydrocephalus. b | 3 T magnetic resonance angiogram showing the ruptured basilar bifurcation. c | 3D rotational angiography confirmed the presence of a wide-necked aneurysm. d | The aneurysm following treatment using endovascular coiling, which had an excellent result. Abbreviation: ADPKD, autosomal dominant polycystic kidney disease.
Figure 6
Figure 6
Surgical and angiographic techniques for the treatment of intracranial aneurysms. a | Microsurgical clipping. b | Endovascular coiling. c | Stent-supported coiling. d | Flow-diverter therapy.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Iglesias C, et al. Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935–1980. Am J Kidney Dis. 1983;2:630–639. - PubMed
    1. Collins AJ, et al. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis. 2012;59(Suppl. 1):e1–e420. - PubMed
    1. Ong A, Harris P. Molecular pathogenesis of ADPKD: the polycystin complex gets complex. Kidney Int. 2005;67:1234–1247. - PubMed
    1. Grantham J, et al. Volume progression in polycystic kidney disease. N Engl J Med. 2006;354:2122–2130. - PubMed
    1. Grantham J, Chapman A, Torres V. Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. Clin J Am Soc Nephrol. 2006;1:148–157. - PubMed

Publication types

MeSH terms